Naim Alkhouri
Summit Medical Group (United States)(US)Cleveland Research (United States)(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Diet, Metabolism, and Disease, Liver Diseases and Immunity, Hepatitis C virus research
Most-Cited Works
- → A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis(2024)1,493 cited
- → Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial(2019)741 cited
- → A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH(2021)672 cited
- → NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances(2018)569 cited
- → Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials(2020)447 cited
- → Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal(2009)407 cited